共 10 条
[1]
Bauernfeind A., Jungwirth R., Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefurox- ime, cefaclor and cefadroxil, Infection, 19, pp. 353-362, (1991)
[2]
Cullmann W., Dick W., Cefpodoxime: Comparable evaluation with other orally available cephalosporins. With a note on the role of β-lactamases, Zbl Bakt, 273, pp. 501-517, (1990)
[3]
Cullmann W., Survey of antimicrobial resistance to oral antibiotics in Italy, Chemotherapy (Basel), 39, pp. 13-21, (1993)
[4]
Holt H.A., Bywarter M.J., Reeves D.S., In-vitro activity of cefpodoxime against 1834 isolates from domiciliary infection at 20 UK centres, J Antimicrob Chemother, 26, pp. 7-12, (1990)
[5]
Sheppard M., King A., Phillips I., In vitro activity of cefpodoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents, Eur J Clin Microbiol Infect Dis, 10, pp. 573-581, (1991)
[6]
Soussy C.J., Kitzis M.D., Thabaut A., Et al., Activitéantibacterienne in-vitro d’une nouvelle cephalosporine orale, le cefixime, Résultats d’une étude multicentrique, Pathol Biol, 37, pp. 528-533, (1989)
[7]
Valle T., Jalanko E., Scheinin L., Renkonen O.V., In vitro activity of Ro 15-8074 and Ro 19-5247, Eur J Clin Microbiol, 6, pp. 167-169, (1987)
[8]
Wiedemann B., Luhmer E., Zuhlsdorf MT. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, Infection, 19, pp. 363-369, (1991)
[9]
Wiedemann B., Luhmer E., Zuhlsdorf M.T., Microbiological evaluation of cefpodoxime proxetil (See comments), Drugs, 42, pp. 6-12, (1991)
[10]
Ballows A., Hausler W.J., Herrmann K.L., Isenberg H.D., Shadomy H.J., Manual of Clinical Microbiology, (1991)